PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹968 Cr | ₹660 Cr | ₹257 Cr | ₹356 Cr | ₹667 Cr |
What is the latest Cash Flow from Operating Activities ratio of PFIZER ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹968 Cr |
| Mar2025 | ₹660 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹356 Cr |
| Mar2022 | ₹667 Cr |
How is Cash Flow from Operating Activities of PFIZER Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹968 Cr | 46.66 | |
| Mar2025 | ₹660 Cr | 156.87 | |
| Mar2024 | ₹257 Cr | -27.79 | |
| Mar2023 | ₹356 Cr | -46.68 | |
| Mar2022 | ₹667 Cr | - | |
Compare Cash Flow from Operating Activities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹17,405.8 Cr | -0.1% | -5.8% | -25.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -0.1% |
-5.8% |
-25.4% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses